Skip to content
Log in
#software testing Open access

MORTALITY AND ASSOCIATED FACTORS AMONG PEOPLE LIVING WITH HIV NEWLY INITIATED INTO CARE AT BAMENDA REGIONAL HOSPITAL: A RETROSPECTIVE COHORT STUDY

Faustus Ajamah Jude Tsafack Zefack Lucas Tanlaka Mengnjo Onesimus Yongwa Michael Agbor Ashu Selouis Fuanyi Nkengfua Huldah Mbinyui A. Ketchaji
Aug 2026 · World Journal of Advanced Research and Reviews · 0 citations

TL;DR

Mortality among PLHIV in this study was associated with advanced disease, opportunistic diseases, commorbidities and abnormal laboratory findings, and Strengthening early diagnosis, management of opportunistic infections, and monitoring of clinical and laboratory indicators may help reduce mortality in this population.

Abstract

Introduction: Globally and in Africa, HIV mortality is reported to have decreased over the years. Cameroon's national mortality rate was 1.7% in 2023, and there exist regional disparities and underreporting. We assessed the mortality and associated factors among People Living with HIV(PLHIV) initiated into HIV care from January 2021 to December 2023 at the Bamenda regional hospital (BRH) Methods: A retrospective cohort study was conducted from June 2024 to December 2024 at the BRH. Using a non-probabilistic consecutive sampling technique, 331 newly initiated participants on ART were included. Data was collected from medical records using a questionnaire and analyzed using R software version 4.3.1. A multivariable Cox regression model included variables that showed statistical significance and assessed their relationship with mortality while adjusting for potential confounders. Significant predictors of mortality were identified. Results: The mean age of participants was 41.6 ± 11.7 years, and females constituted 57.7%. Opportunistic diseases were present in 19.0% of cases, with tuberculosis (8.2%) being the most common. Key comorbidities included hypertension (8.8%), diabetes (3.9%), and hepatitis B (3.0%). Blood tests showed elevated liver enzymes (ALAT/ASAT: 41.7±23.6 U/L) and high blood sugar (144.4±7.4 mg/dL). In contrast, kidney function (Creatinine: 0.9±0.2 mg/dL) and immune cell counts (Lymphocytes: 1.8±0.7 x10³/μL) appeared normal overall. A cumulative mortality rate of 7.6% over three years (approximately 2.5% per year) was observed. Male sex (AHR=7.83, 95% CI :1.44-42.5, p=0.017), opportunistic diseases (AHR=5.66, 95% CI :1.71-18.7, p=0.004), comorbidities (AHR=6.04, 95% CI :2.02-18.1, p=0.001), Abnormal ALAT/ASAT (p=0.005), and WHO clinical stage III (AHR : 1.1, 95%CI : 1.01 -1.5, p < 0.001), were identified as predictors of mortality. Whereas BMI and ART adherence showed no significance. Conclusion: Mortality among PLHIV in this study was associated with advanced disease, opportunistic diseases, commorbidities and abnormal laboratory findings. Strengthening early diagnosis, management of opportunistic infections, and monitoring of clinical and laboratory indicators may help reduce mortality in this population.

DOI Semantic Scholar
Read PDF

Similar papers

Open access Jul 2026

Incidence and predictors of loss to follow-up among HIV infected adults on antiretroviral therapy in Guji Zone, Southern Ethiopia, 2023

The incidence of LTFU among adults on ART in Guji zone was high, particularly during the first year of treatment, and targeted interventions including enhanced counseling for high-risk groups, community-based ART refill models, and active phone-based tracking systems should be implemented to improve retention.

Dereje Girma, Gemechis Tuke, Zelalem Jebessa et al. · 0 citations
Open access Jul 2026

Implementation of a specialized inpatient HIV care model and in-hospital mortality in South Brazil: a before-after study

Summary Background Advanced HIV disease (AHD) remains a major cause of hospitalization and mortality among people living with HIV (PLHIV). We evaluated the association between implementation of a structured specialist-led inpatient HIV care model and clinical outcomes among hospitalized PLHIV in southern Brazil. Methods We conducted an observational before–after study at a tertiary public hospital in Porto Alegre, Brazil, comparing a pre-intervention period (January 2023–April 2024) with a post-intervention period (May 2024–August 2025). The intervention included a dedicated infectious diseases team, standardized protocols for AHD and opportunistic infections, and rapid antiretroviral therapy (ART) initiation during hospitalization. Adults admitted with AHD were included. Adjusted risk ratios (aRR) for mortality, ICU admission, and a composite adverse outcome were estimated using modified Poisson regression. Findings A total of 963 hospitalizations among 899 unique patients were included (406 pre-intervention; 557 post-intervention). Baseline characteristics were similar between periods. In-hospital mortality declined from 24% to 17% (p = 0.014). In adjusted analyses, the post-intervention period was associated with lower risks of in-hospital mortality (aRR 0.74, 95% CI 0.57–0.96), ICU admission (0.70, 0.57–0.86), and composite adverse outcomes (0.78, 0.67–0.92). Opportunistic infection screening increased, lumbar puncture was performed more frequently, and ART was initiated earlier. Interpretation Implementation of a structured inpatient HIV care model was associated with improved clinical outcomes among PLHIV with AHD. Structured multidisciplinary inpatient HIV care may represent a promising approach to strengthen delivery of WHO-recommended AHD care in hospital settings and warrants further evaluation in controlled studies. Funding Pan American Health Organization (PAHO), US Centers for Disease Control and Prevention (CDC), and Unitaid.

P. M. Fonseca, Andressa Noal, Gisele O. Boff et al. · 0 citations
Open access Jan 2026

Prevalence and Correlates of Dyslipidemia in HIV‐Positive Patients at Selected Public Hospitals in Addis Ababa, Ethiopia, 2025

Dyslipidemia was prevalent among approximately two in three HIV‐positive patients receiving long‐term ART at two tertiary hospitals in Addis Ababa, Ethiopia, highlighting the need for routine lipid monitoring and integrated cardiovascular risk management within HIV care settings in similar urban, tertiary‐care contexts.

Nebiat Adane, Mekoya Mengistu, Tariku Fekadu et al. · 0 citations
Open access Jan 2026

Incidence and Predictors of Tuberculosis Among Adults Living With HIV/AIDS on Antiretroviral Therapy in Central Gondar Zone, Northwest Ethiopia: A Multicenter Retrospective Follow-Up Study

Tuberculosis incidence was relatively low, while isoniazid use was protective, and poor adherence, opportunistic infections, and large family size increased risk, while isoniazid use was protective.

Wabiw Addis, Adugnaw Zeleke, S. Nigatu et al. · 0 citations
Open access Aug 2026

Prevalence and Risk Factors of Generalized and Abdominal Obesity among People Living with HIV on Antiretroviral Therapy: A Cross-sectional Study from a Tertiary Care ART Centre, Bangalore, India

High CD4 count was the risk factor for generalized obesity and female sex, being married and high CD4 count were risk factors for abdominal obesity among PLHIV.

Ramesh Masthi NR, Pruthvi S, Lavanya R et al. · 0 citations
Open access Aug 2026

Impact of maternal and neonatal factors on mortality in the first six weeks of life: A comprehensive cohort study in Kinshasa, DR Congo

Results underscore the crucial importance of high-quality obstetric and neonatal care, as well as antenatal monitoring, for improving newborn survival and call for strengthened antenatal care, improved screening and management of at-risk newborns in healthcare facilities, and the integration of these indicators into strategies for reducing neonatal mortality in resource-limited settings.

F. Kabasubabo, H. Bezanahary, Julien Magne et al. · 0 citations

Related blog posts

MIT News · Artificial Intelligence Aug 17, 2026

Q&A: Rethinking how innovation happens

In his latest book, Professor Eugene Fitzgerald examines the forces that turn breakthroughs into value — and why innovation resists simple formulas.